Kalogon
Melbourne, US · Founded 2022 · Delaware corporation · 4 known investors
Find your way into Kalogon
Sign up to see every warm intro you have to Kalogon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kalogon team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kalogon develops advanced seating technologies, including smart cushions, aimed at improving comfort and health for people who must sit for extended periods. The company draws on clinical research and customer feedback to address the health risks and discomfort associated with prolonged sitting.
Founders & leadership
Kalogon was founded in 2022 by Aaron Jones and Timothy Balz.






Investors · 4
How we know: Enable Ventures's portfolio page · offering press articles · press coverage · Not right? Tell us
How we know: Florida Opportunity Fund's portfolio page · Not right? Tell us
How we know: offering press articles · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$11.8M disclosed across 4 rounds · 2022–2026
▶$5.7MraisedJun 2026 · 22 investors · Other Health CareRule 506(b)
- Tim BalzExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $5.7M
- Minimum investment
- $10K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$2.9MraisedJun 2026 · 22 investors · Other Health CareRule 506(b)
- Tim BalzExecutive Officer, Director
- Offering amount
- $2.9M
- Amount sold
- $2.9M
- Minimum investment
- $10K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.2MraisedJun 2024 · 17 investors · Other Health CareRule 506(b)
- Arushi RainaDirector
- Timothy BalzExecutive Officer, Director
- Jeff ReadyDirector
- Marcin KubiakDirector
- Mark BergrenDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Minimum investment
- $10K
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.9MraisedAug 2022 · 9 investors · Other Health CareRule 506(b)
- Marcin KubiakDirector
- Tim BalzExecutive Officer, Director
- Mark BergrenDirector
- Jeff ReadyDirector
- Offering amount
- $1.9M
- Amount sold
- $1.9M
- Minimum investment
- $150K
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2022 | $1.2M |
| Department of Health and Human ServicesAdministration for Community Living | Phase I | 2022 | $99.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Kalogon do?
- Kalogon develops advanced seating technologies, including smart cushions, aimed at improving comfort and health for people who must sit for extended periods. The company draws on clinical research and customer feedback to address the health risks and discomfort associated with prolonged sitting.
- Who founded Kalogon?
- Kalogon was founded by Aaron Jones, Timothy Balz in 2022.
- Who are Kalogon's investors?
- Kalogon's investors include Enable Ventures, Florida Opportunity Fund, venVelo, DeepWork Capital.
- How much funding has Kalogon raised?
- Kalogon has disclosed $11.8M raised across 4 rounds.
- Where is Kalogon headquartered?
- Kalogon is headquartered in Melbourne, US.

